Senescence induction universally activates transposable element expression

Cell Cycle. 2018;17(14):1846-1857. doi: 10.1080/15384101.2018.1502576. Epub 2018 Aug 16.

Abstract

Senescent cells constitutively secrete inflammatory cytokines, known as the senescence-associated secretory phenotype (SASP). Previous work has implicated SASP in immune-mediated clearance of senescent cells; however, its regulation remains unknown. Our recent transcriptome profiling study has shown that human senescent human stem and progenitors (s-HSPCs) robustly express genomic transposable elements (TEs) and pathways of inflammation. Furthermore, hypomethylating agents have been previously shown to induce expression of TEs and activate the dsRNA recognition pathway and downstream interferon-stimulated genes, leading to immune mediated cell death. Therefore, to examine whether activation of TEs occurred universally, independent of their modality of senescence induction, we performed transcriptomic analysis in artificially-induced senescent cell-lines and observed a robust activation of TEs. Hence we propose that the expression of TEs might play a role in immune mediated clearance of senescent cells.

Keywords: ERV; ISG; SASP; Senescence; dsRNA; inflammation; transposable elements.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / pharmacology
  • Cellular Senescence / drug effects
  • Cellular Senescence / genetics*
  • DNA Transposable Elements / genetics*
  • Doxorubicin / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Viruses / metabolism

Substances

  • DNA Transposable Elements
  • RNA, Messenger
  • Doxorubicin
  • Azacitidine

Grants and funding

This project was funded by grants from Leukemia Lymphoma Society-Quest for Cures #0863-15, STOP Cancer, Tower Cancer Research Foundation, and the Keck School of Medicine of the University of Southern California, Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases University of Southern California.